These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 523855)

  • 21. [Drug therapy in chronic renal insufficiency].
    Rahn KH
    Z Allgemeinmed; 1975 Jul; 51(19):876-9. PubMed ID: 1179758
    [No Abstract]   [Full Text] [Related]  

  • 22. [The influence of l-histidine substitution on protein metabolism (transferrin and complement system) and renal anaemia in endstage renal failure (author's transl)].
    Kult J; Röckel A; Hennemann H; Heidland A
    Med Klin; 1974 Nov; 69(45):1845-9. PubMed ID: 4444649
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renal insufficiency: definition and causes (author's transl)].
    Watshinger B
    Acta Med Austriaca; 1980; 7(4-5):120-4. PubMed ID: 7246012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
    Lin JL; Leu ML
    Nephrol Dial Transplant; 1996 Sep; 11(9):1891-3. PubMed ID: 8918652
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].
    Lesne M
    J Pharm Belg; 1988; 43(3):212-32. PubMed ID: 3171871
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent drug management advances in renal insufficiency.
    Fabre J; Balant L; Chavaz A
    Adv Nephrol Necker Hosp; 1974; 4():223-48. PubMed ID: 4219995
    [No Abstract]   [Full Text] [Related]  

  • 28. [Significance of sodium excretion fraction determination with a view to heavy doses of furosemide in patients with chronic renal failure (author's transl)].
    Erben J; Schück O; Zahradník J
    Cas Lek Cesk; 1981 Jun; 120(23):695-8. PubMed ID: 7249034
    [No Abstract]   [Full Text] [Related]  

  • 29. [Medication dosage in kidney insufficiency].
    Reubi F
    Schweiz Med Wochenschr; 1974 Jul; 104(27):968-71. PubMed ID: 4460236
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatic clearance of drugs in kidney failure].
    Balant L
    Nephrologie; 1983; 4(2):45-7. PubMed ID: 6136004
    [No Abstract]   [Full Text] [Related]  

  • 31. [Progress in hemofiltration research (author's transl)].
    Zhang X
    Zhonghua Nei Ke Za Zhi; 1981 Jul; 20(7):439-42. PubMed ID: 7327066
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antisepsis and antibacterial treatment in connection with intensive medicine and dialysis therapy (author's transl)].
    Höffler D
    Immun Infekt; 1974 May; 2(2):123-7. PubMed ID: 4468266
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs and the kidney.
    Evans DB
    Br J Hosp Med; 1980 Sep; 24(3):244, 246-7, 249-51. PubMed ID: 7437614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug dosing in chronic kidney disease.
    Gabardi S; Abramson S
    Med Clin North Am; 2005 May; 89(3):649-87. PubMed ID: 15755472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study on calcium metabolism in renal failure--clinical aspects and treatment (author's transl)].
    Asai K; Watanabe Y; Ohkura T; Sakamoto N
    Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1505-21. PubMed ID: 7206329
    [No Abstract]   [Full Text] [Related]  

  • 36. Considerations in the use of drugs in patients with renal failure.
    Le Sher DA
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):570-6. PubMed ID: 977798
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of the pharmacokinetics of drugs in renal failure].
    Nadzhimutdinov KN; Krakovskiĭ ME
    Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
    [No Abstract]   [Full Text] [Related]  

  • 38. [Polypragmasy at the treatment of old people (author's transl)].
    Siering H
    Z Alternsforsch; 1982; 37(1):11-6. PubMed ID: 7064484
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes of pharmacokinetics in uremia with special reference to drug catabolism].
    Leber HW
    Med Klin; 1976 Aug; 71(34):1321-30. PubMed ID: 785180
    [No Abstract]   [Full Text] [Related]  

  • 40. [Circulatory and metabolic changes during submaximum exertion in patients with chronic renal failure treated by regular dialysis (author's transl)].
    Tomásek R; Lisý Z; Válek A; Pick P; Straková M
    Sb Lek; 1975 Sep; 77(9):278-88. PubMed ID: 1179147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.